Eli Lilly and Company (NYSE: LLY) today announced the presentation of data about personal attitudes toward migraine among people without the disease.1 These data are from the OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine) study. The findings demonstrate that discriminating attitudes towards people with migraine, unconscious or otherwise, are deep-rooted and advanced by a lack of understanding about the disease.1 They point to a need for greater respect for, and appreciation of, this serious neurologic disease.1 These data will be presented today, Saturday, July 13, 2019, at the 61st Annual Scientific Meeting of the American Headache Society taking place in Philadelphia.
The OVERCOME study included more than 20,000 people with migraine and nearly 10,000 people without migraine. Within the sub-group who did not have the disease, 2,000 were surveyed about their attitudes toward people with migraine.1 More than 40 percent of people who knew at least one person with migraine felt that those living with the disease use their migraine as an excuse to avoid family, work, or school commitments and/or exaggerate their symptoms.1 More than one third (36%) believed that someone’s migraine attacks are caused by their own unhealthy behavior.1
